Market Insights and Analysis: Drug Screening Market Overview and Projections (2023-2028)
The Global Drug Screening Market size was valued at USD 7.5 billion in 2022 and is projected to grow at a CAGR of around 11.33% during the forecast period, i.e., 2023-28.
Top leading companies in the Drug Screening Market includes:
Labcorp, Quest Diagnostics, Abbott Laboratories, Orasure Technologies, Alfa Scientific Designs, ThermoFisher Scientific, Dragewerk, Lifeloc Technologies, MPD Inc., Omega Laboratories, Premier Biotech, Psychmedics, Siemens Healthineers, Shimadzu Corporation, Hoffmann-La Roche Ltd., Others
Recent Developments:
- In June 2023, Quest Diagnostics, Inc. (DGX) entered into a partnership with Coriell Life Sciences to offer pharmacogenomics testing services to specific members of medical plans. This test assesses the influence of various genes and their variations on how a person responds to medications.
Access the detailed PDF Sample report – https://www.marknteladvisors.com/query/request-sample/drug-screening-market.html
Report Segmentation:
The market is categorized into the following segments in the report:
By Product & Service
-Drug Screening Product
-Analytical Instruments
–Breathalyzers
–Immunoassay Analyzer
–Chromatography Instruments
-Rapid Testing Devices
-Oral Fluid Testing Devices
-Consumables
–Assay Kits
–Sample Collection Devices
–Calibrators & Controls
–Other Consumables
-Drug Screening Service
By Sample Type
-Urine Samples
-Breath Samples
-Oral Fluid Samples
-Hair Samples
-Others
- the drug screening market size for urine samples is projected to significantly expand during 2023-28 due to the rising demand for drug testing across different sectors, including workplaces, sports, & law enforcement.
By End Users
-Drug Testing Laboratories
-Workplaces
-Criminal Justice & Law Enforcement Agencies
-Hospitals
-Drug Treatment Centers
-Individual Users
-Pain Management Centers
-Schools & Colleges
Explore Our Comprehensive Study Reports – https://www.marknteladvisors.com/research-library/drug-screening-market.html
Drug Screening Market Geographic Reach:
The Geographic Reach of the Drug Screening Market evaluates the spread and significance of Drug Screening market consumption across different regions/country, emphasizing areas with the largest market size and the most promising growth potential.
- North America: US, Canada, Mexico
- Europe: Germany, The UK, France, Spain, Italy, Rest of Europe
- Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, South Africa, Rest of MEA
Note: If you require specific information not covered in the current report, we can provide it through customized option
Related Reports: –
https://www.openpr.com/news/3488971/minimally-invasive-surgery-market-size-share-and-development
https://www.openpr.com/news/3488971/minimally-invasive-surgery-market-size-share-and-development
https://www.openpr.com/news/3403717/global-managed-siem-services-market-reach-usd-7-12-billion
https://www.openpr.com/news/3403712/gcc-digital-advertising-market-poised-for-a-9-42-cagr-market
https://www.openpr.com/news/3403712/gcc-digital-advertising-market-poised-for-a-9-42-cagr-market
Why choose Us?
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
For Media Inquiries, Please Contact:
Call: +1 628 895 8081 | +91 120 4278433
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
